人参皂苷联合地塞米松对刀豆蛋白所致肝损伤模型大鼠肝功能保护作用及相关机制研究
本文选题:人参皂苷 切入点:地塞米松 出处:《东南大学学报(医学版)》2016年01期 论文类型:期刊论文
【摘要】:目的:探讨人参皂苷(GS)联合地塞米松(Dex)对刀豆蛋白所致肝损伤模型大鼠肝功能的保护作用,并分析其相关机制。方法:将Wistar大鼠40只按随机数字表法分为5组(每组8只):模型组、GS组、Dex组、GS+Dex组及对照组。模型组即建立刀豆蛋白诱导肝损伤模型;GS组、Dex组即分别给药Dex和GS;GS+Dex组则使用Dex和GS联合给药;对照组不给予任何干预。观察记录血清丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、脂质过氧化物丙二醛(MDA)和超氧化物歧化酶(SOD)水平,肝组织中核转录因子kappa B(NF-κB)P65的表达及肿瘤坏死因子-α(TNF-α)和γ-干扰素(IFN-γ)含量变化。并进行肝组织病理学检查。结果:模型组的ALT和AST水平与对照组比较显著上升(t=4.570、4.513,P0.01);GS和Dex单独及联合给药组的ALT和AST水平与模型组比较均明显降低(P0.05);GS+Dex组ALT水平降低程度显著大于GS组和Dex组(t=2.263、3.072,P0.05),AST水平也如此(t=2.829、2.765,P0.05)。模型组大鼠肝匀浆中的MDA水平与对照组相比上升,而SOD活性显著降低(t=7.515、8.514,P0.01),GS组的MDA水平、SOD活性与模型组比较差异无统计学意义(P0.05),GS+Dex组MDA水平降低和SOD活性升高程度显著大于Dex组(t=2.287、2.722,P0.05)。GS+Dex组大鼠体重显著高于模型组及GS组(t=2.942、2.327,P0.05)。模型组的NF-κB P65的蛋白表达与对照组比较显著上调(t=9.428,P0.01),GS+Dex组下调NF-κB P65蛋白表达的程度明显大于GS组和Dex组(t=6.428、5.246,P0.05)。模型组的TNF-α和IFN-γ水平与对照组比较显著上升(t=19.235、25.171,P0.01),GS+Dex组TNF-α水平降低程度显著大于GS组和Dex组(t=2.313、9.053,P0.05),GS+Dex组IFN-γ水平降低程度亦显著大于GS组和Dex组(t=5.171、8.933,P0.05)。结论:GS联合Dex可有效保护刀豆蛋白所致肝损伤模型大鼠的肝功能,其机制可能与抑制氧化应激、抑制NF-κB P65活性、下调TNF-α含量、调节免疫作用有关。
[Abstract]:Objective: to investigate the protective effect of ginsenoside GSH combined with dexamethasone Dexon on liver function in rat model of liver injury induced by concanavalin. Methods: forty Wistar rats were randomly divided into 5 groups (8 rats in each group: model group, GS group, Dex group, GS Dex group and control group). The model group established concanavalin induced liver injury model. Dex and GSG GS Dex group were treated with Dex and GS respectively. The levels of serum alanine aminotransferase (alt), aspartate aminotransferase (AST), lipid peroxide malondialdehyde (MDA) and superoxide dismutase (SOD) were observed and recorded in the control group. The expression of nuclear transcription factor kappa Bu NF- 魏 B p65 and the contents of tumor necrosis factor- 伪 (TNF- 伪) and interferon- 纬 (IFN- 纬) in liver tissue were also detected. Results: the levels of ALT and AST in the model group were significantly higher than those in the control group, and the levels of ALT and AST in the model group were significantly higher than those in the control group. Compared with the model group, the levels of ALT and AST in the single and combined administration groups were significantly lower than those in the model group. The level of ALT in the Dex group was significantly higher than that in the GS group and the Dex group. The same was true of the ALT level in the liver homogenate of the model group and the control group. The level of MDA in the liver homogenate of the model group was higher than that of the control group, and the level of ALT in the liver homogenate of the model group was higher than that of the control group. However, the activity of SOD decreased significantly in the GS group (7.515) and the MDA level in the GS group. There was no significant difference between the model group and the model group. The decrease of MDA level and the increase of SOD activity in the Dex group were significantly higher than those in the Dex group (2.2872.722), P0.05.GS Dex group was significantly higher than that in the model group and GS group, the body weight of the rats in the GS group was significantly higher than that in the model group and GS group. The protein expression of NF- 魏 B p65 in the model group was significantly up-regulated than that in the control group. The down-regulation of NF- 魏 B p65 protein expression in the GS Dex group was significantly higher than that in the GS group and the Dex group. The levels of TNF- 伪 and IFN- 纬 in the model group were significantly higher than those in the control group, and the levels of TNF- 伪 and IFN- 纬 in the GS Dex group were significantly higher than those in the GS Dex group. The level of IFN- 纬 in Dex group was significantly higher than that in GS group and Dex group. Conclusion the level of IFN- 纬 in GS group and Dex group was significantly higher than that in GS group and Dex group. Conclusion the liver function of rats with liver injury induced by concanavalin can be effectively protected by combining with Dex. The mechanism may be related to inhibition of oxidative stress, inhibition of NF- 魏 B p65 activity, down-regulation of TNF- 伪 content and regulation of immune function.
【作者单位】: 上海市第七人民医院药学部;
【基金】:上海市第七人民医院“七院新星”人才培养项目(XX2012-026)
【分类号】:R575
【参考文献】
相关期刊论文 前1条
1 王国华;刘风玲;;人参皂甙Rg3抗肿瘤作用机制研究进展[J];中国医药导刊;2015年03期
【二级参考文献】
相关期刊论文 前10条
1 吴永娟;胡道珍;王敬忠;沈正林;;紫杉醇的抗肿瘤机制及研究进展[J];中国医药导刊;2010年02期
2 齐平;靳颖华;张为革;宋宏锐;;分子靶点抗肿瘤药物研究进展[J];中国医药导刊;2014年02期
3 陈大富;庄永敬;黄建强;;人参皂甙Rg3联合FOLFOX 4方案治疗直肠癌的疗效观察[J];临床肿瘤学杂志;2013年02期
4 辛颖;姜新;崔俊生;倪劲松;;人参皂苷Rg3抑制B16黑色素瘤新生血管生成及其机制的探讨[J];中华肿瘤防治杂志;2010年08期
5 于学涛;王淑萍;;人参皂苷Rg3联合化疗治疗对胃癌术后患者的临床观察[J];中华肿瘤防治杂志;2010年10期
6 安宁;朱文;;人参皂苷Rg3抗肿瘤作用机制研究进展[J];现代肿瘤医学;2008年04期
7 许霞辉;贺兼斌;张平;;人参皂苷Rg3联合苏拉明对小鼠肺癌生长影响及其机制的探讨[J];中华肿瘤防治杂志;2013年02期
8 李雪甫;刘艳文;王永实;;人参皂甙Rh2联合顺铂对食管癌细胞的杀伤作用[J];现代肿瘤医学;2014年03期
9 陈曦;陈鲁;;人参皂苷Rg3的抗肿瘤作用研究进展[J];中国当代医药;2011年36期
10 侯俊杰;宋艳秋;康丽花;赵玲玲;单既英;韩倩;;20(R)-人参皂甙Rg3对老年肿瘤患者放、化疗后的辅助治疗效果[J];中国老年学杂志;2011年20期
相关博士学位论文 前1条
1 鲁培;人参皂甙Rg3治疗食管癌分子机制的实验性研究[D];郑州大学;2013年
相关硕士学位论文 前4条
1 钱伶凌;人参皂甙Rg3对乳腺癌细胞系的抑制作用[D];浙江工业大学;2010年
2 王小燕;人参皂甙Rg3联合小剂量化疗对乳腺癌抗血管作用的实验研究[D];大连医科大学;2010年
3 马利军;人参皂甙Rg3上调Fas蛋白诱导乳腺癌MCF-7细胞的凋亡[D];山西医科大学;2010年
4 章馨允;人参皂甙Rh2联合化疗对T细胞淋巴瘤协同增效的分子机制[D];天津医科大学;2013年
【相似文献】
相关期刊论文 前10条
1 王欢;王秀兰;白石磊;王图雅;;大鼠幽门结扎性“蒙医病症肝损伤模型”的建立[J];中国民族医药杂志;2013年12期
2 张明;;两种肝损伤模型的建立及其切片观察[J];动物医学进展;2010年07期
3 刘晓岩;李凤云;池志宏;王银叶;;口服1,6-二磷酸果糖对动物肝损伤模型的保护作用(英文)[J];Journal of Chinese Pharmaceutical Sciences;2006年03期
4 刘洪波;范学工;刘悦晖;张磐;周蓉蓉;李宁;黄建军;;肝损伤模型小鼠高迁移率族蛋白-1的表达[J];生命科学研究;2008年02期
5 茹仁萍;吴锡铭;朱幸芳;;小鼠慢性免疫性肝损伤模型建立与筛选[J];医学研究通讯;2005年12期
6 范新娟;洪海;唐芳;刘芳;陈少红;赵国强;;应用SELDI-TOF-MS技术对肝损伤模型大鼠血清蛋白质表达谱的比较分析[J];中国病理生理杂志;2007年12期
7 吕锦芳;冯保明;宁康健;应如海;姜锦鹏;;当归对肝损伤模型小鼠部分糖代谢指标的影响[J];安徽科技学院学报;2012年06期
8 张茜茜;;小鼠肝病模型中细菌的移位和肠道微生物群的变化[J];临床肝胆病杂志;2012年06期
9 张转,陈廖斌,么冬爱,汪晖,张正彬,汪玉霞;小鼠肠系膜上动脉缺血再灌注肝损伤模型的建立[J];中华实验外科杂志;2001年04期
10 赵敏,杨杏芬,池莉平,陈瑞仪,黄俊明;小鼠急性四氯化碳肝损伤模型的建立及在保健食品筛选中的应用[J];华南预防医学;2002年05期
相关会议论文 前3条
1 许秀举;沈丽君;;乙醇对肝损伤模型建立的研究进展[A];低碳生活与健康损害论坛——中国环境诱变剂学会风险评价专业委员会全国第十三届学术会议暨第四届第5次委员会会议论文集[C];2011年
2 张引强;唐旭东;王凤云;刘燕玲;;刀豆蛋白A(Con A)肝损伤模型的研究应用[A];第二十二届全国中西医结合消化系统疾病学术会议暨消化疾病诊治进展学习班论文汇编[C];2010年
3 张引强;唐旭东;王凤云;;刀豆蛋白(con A)肝损伤模型的研究应用[A];中华中医药学会脾胃病分会第二十次全国脾胃病学术交流会论文汇编[C];2008年
相关硕士学位论文 前2条
1 梁雪琰;基于CCL4肝损伤大鼠模型的护肝片降ALT作用机制研究[D];黑龙江中医药大学;2012年
2 李淑萍;犬四氯化碳肝损伤模型的超声影像变化[D];福建农林大学;2014年
,本文编号:1573730
本文链接:https://www.wllwen.com/yixuelunwen/xiaohjib/1573730.html